GlassScriptPhysician profile
Roger William Thomas
NPI 1851321434
$972.36
in general payments reported to CMS, 2019-2025
15 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $216 · 2023: $378 · 2024: $190 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $756.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $231.96 | 2023 | Intracept |
| Nevro Corp. | $148.61 | 2022-2024 | Senza |
| Forte Bio-Pharma LLC | $84.65 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Nalu Medical, INC. | $69.87 | 2024 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $63.38 | 2024-2025 | Belbuca |
| Merz Pharmaceuticals, LLC | $56.66 | 2022 | |
| Alnylam Pharmaceuticals INC. | $47.71 | 2023-2024 | Amvuttra |
| Biohaven Pharmaceutical Holding Company LTD. | $47.13 | 2022 | |
| Redhill Biopharma INC. | $46.33 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.32 | 2025 | Relistor |
| Boston Scientific Corporation | $37.68 | 2025 | Intracept |
| Vertex Pharmaceuticals Incorporated | $34.32 | 2025 | |
| Painteq LLC | $28.30 | 2023 | Painteq |
| Vertos Medical, INC. | $19.64 | 2024 | Mild Device Kit |
| Abbvie INC. | $15.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.